InMode (INMD) Q4 2025 earnings review
Revenue Returns to Growth, But Margins Compress
InMode ended a challenging 2025 with a stabilization signal: Q4 revenue grew 6% YoY to $103.9M, driven by record performance in Europe. However, the recovery comes at a steep price. Profitability is deteriorating as the sales mix shifts away from the high-margin U.S. market. Non-GAAP Operating Margin compressed to 27% (from 32% a year ago), and FY26 guidance forecasts a structural drop in Gross Margins to 75-77%. While the company holds a massive $555M cash pile, the narrative has shifted from 'high-growth compounder' to 'stabilization with lower efficiency.'
🐂 Bull Case
The pivot to international markets is working. Europe delivered record revenue in Q4, and international operations are offsetting continued weakness in North America. This geographic diversification reduces reliance on the interest-rate-sensitive U.S. consumer.
Consumables and service revenue grew 8% YoY to $21.5M. This recurring revenue stream indicates that despite lower capital equipment sales, the existing installed base remains active and procedure volumes are stabilizing.
🐻 Bear Case
The 'InMode Premium' is fading. FY26 guidance calls for Non-GAAP Gross Margins of 75-77%, a sharp decline from the historical 83-85% range. The shift toward lower-margin international sales and tariff impacts are creating a new, less profitable baseline.
Management's FY26 revenue guidance of $365-$375M implies roughly 0% growth vs FY25 ($370.5M). Despite 'signs of stabilization,' the company does not see a return to topline expansion in the near term.
⚖️ Verdict: ⚪
Neutral. The return to revenue growth in Q4 is a relief, and the balance sheet is a fortress. However, the FY26 outlook for flat revenue and significantly lower margins suggests the company is stuck in a transition period with no immediate catalyst for earnings expansion.
Key Themes
Profitability Reset (Gross Margin)
Management guided FY26 Non-GAAP Gross Margins to 75-77%. This is a significant deceleration from the 79% reported in FY25 and 81% in FY24. This confirms that the mix shift toward international distributors and potential tariff costs are not temporary headwinds but structural changes weighing on the model.
International & European Strength
Europe is the new engine. While the U.S. struggles with macro headwinds, European operations hit record revenues in Q4. Previous quarters highlighted a strategic push into Europe (10 direct countries), Asia, and Latin America. This diversification is the primary reason revenue turned positive in Q4 despite U.S. weakness.
North American Restructuring
The U.S. market remains a drag. In response, InMode has unified its North American operations (East, West, Canada) under a single leadership structure. While intended to improve focus, this follows several quarters of missed expectations in the region. The flat FY26 guidance suggests this restructuring will take time to yield growth.
New Product Cycles
Management confirmed the planned launch of two new laser-based platforms in 2026. Given the stagnation in the core RF aesthetics business, the success of these new modalities is critical for breaking out of the current zero-growth trend.
Capital Allocation Shift
InMode returned $127.4M to shareholders via buybacks in 2025, but the pace has slowed compared to 2024 ($285M). With $555M in cash (approx. 30% of market cap) and no debt, the company has massive optionality but lacks a clear signal on whether it will pursue aggressive M&A or continue buybacks at the same scale.
Other KPIs
Stable. Up from $510M in Q2 2025. The balance sheet remains a fortress, providing a floor to the valuation and flexibility for M&A or buybacks.
Accelerating. Growth of +8% YoY is an improvement over the +3% seen for the full year. This is a vital health check, proving that despite fewer machine sales, doctors are actually using the devices.
Decelerating. Down significantly from $82.8M in 24Q4, though the comparison is skewed by a one-time $55M tax benefit in the prior year period. Normalized Non-GAAP Net Income fell slightly to $29.4M (-5% YoY).
Guidance
Stable/Stagnant. The midpoint ($370M) is effectively flat vs FY25 actuals ($370.5M). This guidance contradicts a 'recovery' narrative, implying that international gains will merely offset continued U.S. weakness.
Decelerating. A major drop from FY25 (79%) and FY24 (81%). This indicates structural pressure, likely due to a higher mix of lower-margin international distribution deals and potentially unmitigated tariff costs.
Decelerating. At midpoint ($1.455), EPS is expected to fall ~9% from FY25 ($1.60). Profitability is shrinking faster than revenue is stabilizing.
Key Questions
Gross Margin Floor
Guidance implies a 300bps drop in gross margin for 2026. Is this the new permanent baseline due to geographic mix, or are there temporary factors (tariffs, launch costs) that will eventually roll off?
North American Stabilization
With the restructuring of the North American sales organization, when do you expect U.S. revenue to return to growth? Is the flat FY26 guidance assuming a further decline in the U.S. offset by Europe?
Cash Utilization
With $555M in cash and the stock trading at suppressed multiples, why slow the buyback pace? Are you preserving capital for a specific M&A target in 2026?